Biorasi

Biorasi

研究服务

Aventura,Florida 73,293 位关注者

Your Go-To CRO

关于我们

For over 20 years, Biorasi has been to go-to CRO (Contract Research Organization) for small to midsized biopharma companies, optimizing speed-to-market solutions across global clinical trials in oncology, neurology, dermatology, and cell and gene therapy. Our #OneTeam of leaders and clinical study experts focus on the qualities necessary to succeed in today’s clinical trial industry – flexibility, reliability, and transparency. It is Biorasi’s mission to be a catalyst for growth, innovation, and evolution in the field of clinical research – moving the industry forward while improving results for our partners and outcomes for their patients. Our culture is based on our strong commitment to building true partnerships with our sponsors. We approach all of our trials with urgency, commitment, and resolve. Biorasi is able to directly support studies in the Americas, Europe, and APAC. We have received multiple accolades including placement in the INC 500 and 5000 list of fastest-growing companies in America, Frost and Sullivan’s Entrepreneurial Company of the Year for the CRO Industry, and the CRO Leadership Award from Life Science Leader magazine.

网站
https://www.biorasi.com
所属行业
研究服务
规模
201-500 人
总部
Aventura,Florida
类型
私人持股
创立
2002
领域
Contract Clinical Research、Complex Clinical Trials、Digital Therapeutics、Clinical Trial Rescue、Nephrology、Dermatology、Data Sciences、Rare Diseases、Clinical Trial Management、Neurology、Clinical Research Sites、Oncology、Fast and Agile Clinical Trials、Decentralized Trials、Remote Solutions、Patient Centricity、Regenerative Medicine、Medical Device Clinical Trials、Innovative Project Management和COVID-19 Trials

地点

  • 主要

    18851 NE 29th Ave

    Suite 800

    US,Florida,Aventura,33180

    获取路线

Biorasi员工

动态

  • 查看Biorasi的公司主页,图片

    73,293 位关注者

    Doff your caps to our CEO Chris O'Brien on teaching his first Harvard Business School class. The entire Biorasi #OneTeam is very proud!

    查看Chris O'Brien的档案,图片

    Chief Executive Officer at Biorasi

    I had great fun yesterday teaching a class of aspiring #biotech and #pharma #entrepreneurs at Harvard Business School. The class is a mix of MBA and bio PhD students. I haven't seen this kind of pairing elsewhere. The power and connectivity of the Harvard ecosystem for life sciences was fully on display. At Biorasi, we are privileged to support and work with many emerging biotech and pharma clients. Nevertheless, it's really motivating to meet the next generation of founders. Thank you Satish Tadikonda and William Marks for inviting me. You guys are building something special!

    • 该图片无替代文字
  • Biorasi转发了

    查看Vitali Hoffmann的档案,图片

    Clinical Trial Leadership and Strategy, Daily Posts, Weekly Blog, Monthly Newsletter > Free hilarious CRA idiot test on my website. Subscribe to the only Newsletter you need.

    A Neglected Cornerstone of Clinical Trials: Investigator Site File ? One of the most overlooked yet critical aspects of site management is the regular review of the Investigator Site File (ISF). Despite its importance, ISF neglect is a common issue, leading to findings and challenges during: ??? Audits: Missing documents or outdated versions. ??? TMF Checks: Inconsistent filing with the Trial Master File. ??? Metrics Reviews: Unclear tracking of site progress and compliance. ?? Site Findings: Avoidable discrepancies impacting trial quality. ? Why Does This Happen? ?? - Time Constraints ? - Lack of Training ? - Bad Process ? I’ve found that the root cause often lies in an overly complicated ISF-TMF checklist, which makes it difficult for the CRA to perform a quick and simple check. This complexity often leads to distress, delays, and excuses to shift focus to other priority tasks at the site. ? How Can We Improve? ?? Bring on an experienced team to design an ISF-TMF checklist that doesn’t require an energy drink to figure out where to pick up. The checklist must clearly show: ? Which documents have been checked in the past, ? Which are pending, and ? Which are new since the last visit. Additionally, the fields for CRAs to check must be straightforward, enabling the review to be completed easily within 30 minutes to 1 hour per visit. This approach will ensure regular checks, eliminate backlogs, and improve site compliance. ? What has been your experience with ISF maintenance? ?? Share your thoughts and tips below! ? #ClinicalResearch #InvestigatorSiteFile #ISF #TMF #Audits #ClinicalTrialManagement #SiteQuality

    • 该图片无替代文字
  • Biorasi转发了

    查看Vitali Hoffmann的档案,图片

    Clinical Trial Leadership and Strategy, Daily Posts, Weekly Blog, Monthly Newsletter > Free hilarious CRA idiot test on my website. Subscribe to the only Newsletter you need.

    Its YOUR turn to tell: What Makes a Clinical Trial Successful? ?? Clinical trials are the cornerstone of medical progress, but their success doesn’t happen by chance. If you ask 10 people to give you 4 most important key points that matter, do you think you'll get the same answer? I THINK 1. A Well-Thought-Out Protocol Clear objectives, robust methodology, and compliance with regulatory standards are essential. Without a solid foundation, even the best teams can struggle. 2. Qualified Investigators and Sites Experienced investigators and well-equipped sites are essential for smooth trial operations and accurate data collection. 3. Suitable and Motivated Participants Engaged participants are the heart of every trial. Their motivation ensures higher retention rates and reliable outcomes. 4. Correct Execution with Valid Data Clean data, and adherence to protocols ensure reliable results and regulatory approval. What do you think is the most challenging factor in ensuring a trial’s success? Share your thoughts below! ?? #ClinicalResearch #ClinicalTrials #GCP #HealthcareInnovation #ResearchExcellence #ClinicalOperations __________________ Follow me on LinkedIn and subscribe to my newsletter on misterclinical.com Cheers! Vitali

    • 该图片无替代文字
  • Biorasi转发了

    查看Chris O'Brien的档案,图片

    Chief Executive Officer at Biorasi

    Bruce Booth & Atlas Venture are out with their annual year-in-review for #biotech & #pharma. As usual, it's full of interesting stuff, but I was really struck by this slide that shows the hill biopharma companies are climbing. Over the past decade, the average cost to develop a therapy is up by $1 billion. At the same time, success rates have fallen, as has the average value of an approved drug. The science right now is incredibly exciting. Crossed fingers that the other variables required for success -- regulatory frameworks, IP protection, interest rates, etc. -- incentivize break through treatments in 2025 and beyond. The whole presentation is worth your time. https://lnkd.in/eEzQEwDK Recommended, Biorasi!

    • 该图片无替代文字
  • Biorasi转发了

    查看Vitali Hoffmann的档案,图片

    Clinical Trial Leadership and Strategy, Daily Posts, Weekly Blog, Monthly Newsletter > Free hilarious CRA idiot test on my website. Subscribe to the only Newsletter you need.

    Did you select a bad site? When a site badly wants to participate in a clinical trial and makes golden promises at the Site Selection Visit: “We promise top-notch quality, fast enrollment, and perfect compliance!” A few months into the study: Monitor arrives to find missing source docs, overdue queries, and a mysterious ‘lost’ study kit. Managing clinical trials means navigating these gaps between expectations and reality. That is why feasibility process and selection is crucial for success of the trial. It’s not just about setting goals—it’s about consistent follow-through, collaboration, and troubleshooting along the way. Have you ever encountered a site that over-promised but… let’s say, under-delivered? Share your stories below, I’m sure we’ve all been there! #ClinicalResearch #ClinicalTrials #SiteManagement #MonitoringChallenges __________________ Follow me on LinkedIn and subscribe to my newsletter on misterclinical.com Cheers! Vitali

    • 该图片无替代文字
  • 查看Biorasi的公司主页,图片

    73,293 位关注者

    Great insight from Biorasi's Vitali Hoffmann.

    查看Vitali Hoffmann的档案,图片

    Clinical Trial Leadership and Strategy, Daily Posts, Weekly Blog, Monthly Newsletter > Free hilarious CRA idiot test on my website. Subscribe to the only Newsletter you need.

    You're often failing for a simple reason. When was the last time you took a real leap? Like really something that scares you. I remember early in my career when my line manager asked for volunteers to give a short subject matter presentation during the next all-staff meeting. All eyes would be on me, all ears listening. What if I made a mistake or stumbled over my words? I had plenty of excuses to say no, but I decided to take the leap—and it turned out to be the right choice. In our careers and personal lives, growth often requires more than just hard work. It demands courage – the kind that makes us step outside of our comfort zones and explore the unknown. Whether it’s pursuing a new role, starting a side project, or tackling a complex challenge, growth happens when we break away from our familiar routines. Imagine where you could be in one year if you committed to taking bold steps every day. It might feel uncomfortable at first, but as we stretch beyond what we know, we discover potential we never realized we had. If you want something different, dare to do something different. After all, the journey to new horizons always starts with a single step. Have you ever stepped out of your comfort zone? #CareerGrowth #Motivation #Success #PersonalDevelopment #Mindset #Leadership #Inspiration __________________ To stay up-to-date with our industry follow me on LinkedIn and subscribe to my newsletter on misterclinical.com I write about Trends, News, Career, Leadership, AI in Clinical Research. Cheers! Vitali

    • 该图片无替代文字

相似主页

查看职位